329 related articles for article (PubMed ID: 28988589)
1. Efficacy and Biocompatibility of Neutral Icodextrin Peritoneal Dialysis Fluid.
Shimada S; Mori T; Koizumi K; Sato S; Oba-Yabana I; Ohsaki Y; Sato E; Naganuma E; Kurasawa N; Tsuchikawa M; Ito S
Adv Perit Dial; 2016; 32():46-50. PubMed ID: 28988589
[TBL] [Abstract][Full Text] [Related]
2. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
[TBL] [Abstract][Full Text] [Related]
3. Comparison of peritoneal equilibrium test with icodextrin and 2.5% glucose dialysis solutions.
Hwang JC; Wang HY; Wang CT; Chen HC
J Nephrol; 2006; 19(6):758-63. PubMed ID: 17173249
[TBL] [Abstract][Full Text] [Related]
4. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
[TBL] [Abstract][Full Text] [Related]
5. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
[TBL] [Abstract][Full Text] [Related]
6. Icodextrin and peritoneal dialysis: advantages and new applications.
Dousdampanis P; Musso CG; Trigka K
Int Urol Nephrol; 2018 Mar; 50(3):495-500. PubMed ID: 28674854
[TBL] [Abstract][Full Text] [Related]
7. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
Rippe B; Levin L
Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
[TBL] [Abstract][Full Text] [Related]
8. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
[TBL] [Abstract][Full Text] [Related]
9. [Effect of using icodextrin as a starting therapy for peritoneal permeability].
Fernández-Reyes MJ; Bajo MA; del Peso G; Olea T; Sánchez-Villanueva RL; González E; Heras M; Sánchez R; Selgas R
Nefrologia; 2009; 29(2):130-5. PubMed ID: 19396318
[TBL] [Abstract][Full Text] [Related]
10. Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo.
Bajo MA; Selgas R; Castro MA; del Peso G; Diaz C; Sánchez-Tomero JA; Fernandez de Castro M; Alvarez V; Corbí A
Perit Dial Int; 2000; 20(6):742-7. PubMed ID: 11216569
[TBL] [Abstract][Full Text] [Related]
11. Determination of alpha-amylase activity in serum and dialysate from patients using icodextrin-based peritoneal dialysis fluid.
Anderstam B; García-López E; Heimbürger O; Lindholm B
Perit Dial Int; 2003; 23(2):146-50. PubMed ID: 12713081
[TBL] [Abstract][Full Text] [Related]
12. The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test.
Araújo Teixeira MR; Pecoits-Filho RF; Romão Junior JE; Sabbaga E; Marcondes MM; Abensur H
Perit Dial Int; 2002; 22(2):229-33. PubMed ID: 11990408
[TBL] [Abstract][Full Text] [Related]
13. Effects of Icodextrin and Glucose Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids on Effluent Cell Population and Biocompatibility Markers IL-6 and CA125 in Incident Peritoneal Dialysis Patients.
Opatrná S; Pöpperlová A; Lysák D; Fuchsová R; Trefil L; Racek J; Topolčan O
Ther Apher Dial; 2016 Apr; 20(2):149-57. PubMed ID: 26929256
[TBL] [Abstract][Full Text] [Related]
14. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
[TBL] [Abstract][Full Text] [Related]
15. Newly Developed Neutralized pH Icodextrin Dialysis Fluid: Nonclinical Evaluation.
Yamaguchi N; Miyamoto K; Murata T; Ishikawa E; Horiuchi T
Artif Organs; 2016 Aug; 40(8):E158-66. PubMed ID: 27530675
[TBL] [Abstract][Full Text] [Related]
16. Proteome profile of peritoneal effluents in children on glucose- or icodextrin-based peritoneal dialysis.
Bruschi M; Candiano G; Santucci L; Petretto A; Mangraviti S; Canepa A; Perri K; Ghiggeri GM; Verrina E
Nephrol Dial Transplant; 2011 Jan; 26(1):308-16. PubMed ID: 20584736
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
[TBL] [Abstract][Full Text] [Related]
18. Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients.
García-López E; Anderstam B; Heimbürger O; Amici G; Werynski A; Lindholm B
Perit Dial Int; 2005; 25(2):181-91. PubMed ID: 15796147
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients.
Posthuma N; ter Wee P; Donker AJ; Dekker HA; Oe PL; Verbrugh HA
Perit Dial Int; 1999; 19(4):334-42. PubMed ID: 10507814
[TBL] [Abstract][Full Text] [Related]
20. Relationship between effluent levels of beta(2)-microglobulin and peritoneal injury markers in 7.5% icodextrin-based peritoneal dialysis solution.
Minami S; Hora K; Kamijo Y; Higuchi M
Ther Apher Dial; 2007 Aug; 11(4):296-300. PubMed ID: 17661836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
